annual total liabilities:
$590.99M-$26.72M(-4.33%)Summary
- As of today (May 24, 2025), FOLD annual total liabilities is $590.99 million, with the most recent change of -$26.72 million (-4.33%) on December 31, 2024.
- During the last 3 years, FOLD annual total liabilities has fallen by -$6.78 million (-1.13%).
- FOLD annual total liabilities is now -12.67% below its all-time high of $676.69 million, reached on December 30, 2016.
Performance
FOLD Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$596.28M+$5.29M(+0.90%)Summary
- As of today (May 24, 2025), FOLD quarterly total liabilities is $596.28 million, with the most recent change of +$5.29 million (+0.90%) on March 31, 2025.
- Over the past year, FOLD quarterly total liabilities has increased by +$5.19 million (+0.88%).
- FOLD quarterly total liabilities is now -12.65% below its all-time high of $682.60 million, reached on March 31, 2017.
Performance
FOLD quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FOLD Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | +0.9% |
| 3 y3 years | -1.1% | +1.4% |
| 5 y5 years | +58.1% | +77.6% |
FOLD Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | at low | -5.5% | +1.4% |
| 5 y | 5-year | -4.3% | +58.1% | -5.5% | +77.6% |
| alltime | all time | -12.7% | >+9999.0% | -12.7% | +6586.3% |
FOLD Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $596.28M(+0.9%) |
| Dec 2024 | $590.99M(-4.3%) | $590.99M(-2.8%) |
| Sep 2024 | - | $607.73M(-1.5%) |
| Jun 2024 | - | $616.96M(+4.4%) |
| Mar 2024 | - | $591.10M(-4.3%) |
| Dec 2023 | $617.71M(+2.8%) | $617.71M(-2.1%) |
| Sep 2023 | - | $630.85M(+2.0%) |
| Jun 2023 | - | $618.51M(+3.4%) |
| Mar 2023 | - | $597.95M(-0.5%) |
| Dec 2022 | $601.12M(+0.6%) | $601.12M(-4.1%) |
| Sep 2022 | - | $626.96M(-0.0%) |
| Jun 2022 | - | $627.16M(+6.6%) |
| Mar 2022 | - | $588.32M(-1.6%) |
| Dec 2021 | $597.77M(-0.4%) | $597.77M(+3.1%) |
| Sep 2021 | - | $580.05M(+1.2%) |
| Jun 2021 | - | $572.98M(+2.5%) |
| Mar 2021 | - | $559.14M(-6.8%) |
| Dec 2020 | $600.14M(+60.6%) | $600.14M(+3.4%) |
| Sep 2020 | - | $580.27M(+70.4%) |
| Jun 2020 | - | $340.50M(+1.4%) |
| Mar 2020 | - | $335.75M(-10.2%) |
| Dec 2019 | $373.78M(-16.4%) | $373.78M(+11.9%) |
| Sep 2019 | - | $334.02M(+5.0%) |
| Jun 2019 | - | $317.98M(+1.6%) |
| Mar 2019 | - | $313.03M(-30.0%) |
| Dec 2018 | $447.04M(+63.0%) | $447.04M(+4.5%) |
| Sep 2018 | - | $427.64M(+62.0%) |
| Jun 2018 | - | $263.99M(-24.2%) |
| Mar 2018 | - | $348.39M(+27.1%) |
| Dec 2017 | $274.17M(-59.5%) | $274.17M(+1.1%) |
| Sep 2017 | - | $271.10M(-59.7%) |
| Jun 2017 | - | $672.07M(-1.5%) |
| Mar 2017 | - | $682.60M(+0.9%) |
| Dec 2016 | $676.69M(+20.7%) | $676.69M(+16.3%) |
| Sep 2016 | - | $581.63M(+0.3%) |
| Jun 2016 | - | $579.76M(+5.2%) |
| Mar 2016 | - | $551.27M(-1.7%) |
| Dec 2015 | $560.55M | $560.55M(-7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $607.94M(+710.5%) |
| Jun 2015 | - | $75.01M(-15.3%) |
| Mar 2015 | - | $88.61M(+0.9%) |
| Dec 2014 | $87.79M(+7.3%) | $87.79M(+6.8%) |
| Sep 2014 | - | $82.21M(+0.6%) |
| Jun 2014 | - | $81.69M(+0.5%) |
| Mar 2014 | - | $81.27M(-0.7%) |
| Dec 2013 | $81.81M(+100.2%) | $81.81M(+92.0%) |
| Sep 2013 | - | $42.62M(-0.4%) |
| Jun 2013 | - | $42.78M(+7.3%) |
| Mar 2013 | - | $39.88M(-2.4%) |
| Dec 2012 | $40.87M(+1.7%) | $40.87M(-1.4%) |
| Sep 2012 | - | $41.45M(+7.9%) |
| Jun 2012 | - | $38.43M(-4.0%) |
| Mar 2012 | - | $40.02M(-0.4%) |
| Dec 2011 | $40.20M(-15.6%) | $40.20M(-4.5%) |
| Sep 2011 | - | $42.08M(-7.9%) |
| Jun 2011 | - | $45.68M(-7.7%) |
| Mar 2011 | - | $49.49M(+3.9%) |
| Dec 2010 | $47.62M(+251.8%) | $47.62M(+258.8%) |
| Sep 2010 | - | $13.27M(+26.1%) |
| Jun 2010 | - | $10.52M(-24.5%) |
| Mar 2010 | - | $13.94M(+3.0%) |
| Dec 2009 | $13.54M(-76.6%) | $13.54M(-78.1%) |
| Sep 2009 | - | $61.73M(+2.8%) |
| Jun 2009 | - | $60.03M(+7.0%) |
| Mar 2009 | - | $56.12M(-2.8%) |
| Dec 2008 | $57.73M(-9.5%) | $57.73M(-4.0%) |
| Sep 2008 | - | $60.15M(-2.1%) |
| Jun 2008 | - | $61.42M(-0.7%) |
| Mar 2008 | - | $61.85M(-3.1%) |
| Dec 2007 | $63.80M(-53.5%) | $63.80M(+472.5%) |
| Sep 2007 | - | $11.14M(+25.0%) |
| Jun 2007 | - | $8.92M(-94.4%) |
| Mar 2007 | - | $159.33M(+16.2%) |
| Dec 2006 | $137.16M(+112.7%) | $137.16M(+112.7%) |
| Dec 2005 | $64.50M(+1016.7%) | $64.50M |
| Dec 2003 | $5.78M | - |
FAQ
- What is Amicus Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics annual total liabilities year-on-year change?
- What is Amicus Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly total liabilities year-on-year change?
What is Amicus Therapeutics annual total liabilities?
The current annual total liabilities of FOLD is $590.99M
What is the all time high annual total liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total liabilities is $676.69M
What is Amicus Therapeutics annual total liabilities year-on-year change?
Over the past year, FOLD annual total liabilities has changed by -$26.72M (-4.33%)
What is Amicus Therapeutics quarterly total liabilities?
The current quarterly total liabilities of FOLD is $596.28M
What is the all time high quarterly total liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total liabilities is $682.60M
What is Amicus Therapeutics quarterly total liabilities year-on-year change?
Over the past year, FOLD quarterly total liabilities has changed by +$5.19M (+0.88%)